Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives

@article{Jamebozorgi2018CellularAM,
  title={Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives},
  author={Khosro Jamebozorgi and Eskandar Taghizadeh and Daryoush Rostami and Hosein Pormasoumi and George E Barreto and Seyed Mohammad Gheibi Hayat and Amirhossein Sahebkar},
  journal={Molecular Neurobiology},
  year={2018},
  pages={1-13}
}
Parkinson’s disease is a neurodegenerative disorder accompanied by depletion of dopamine and loss of dopaminergic neurons in the brain that is believed to be responsible for the motor and non-motor symptoms in this disease. The main drug prescribed for Parkinsonian patients is l-dopa, which can be converted to dopamine by passing through the blood-brain barrier. Although l-dopa is able to improve motor function and improve the quality of life in the patients, there is inter-individual… CONTINUE READING
BETA

References

Publications referenced by this paper.
SHOWING 1-10 OF 162 REFERENCES

Treatment of Parkinson's disease using cell transplantation.

  • Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2015
VIEW 5 EXCERPTS
HIGHLY INFLUENTIAL

Development and application of CRISPR/Cas9 technologies in genomic editing

Z Cui, Q Renfu, W Jinfu
  • Hum Mol Genet
  • 2018
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…